Project Grant R15AR084182
Award Date
9/25/24
Completion Date
8/31/27
Dollars Obligated
$820K
Awardee
Miami University (T6J6AF3AM8M8)
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Oxford, OH 45056, USA
Similar Awards
This Project Grant award of $248,724 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research into the role of cellular senescence in skeletal muscle loss and dysfunction. The primary objectives are to (1) develop the experimental skills and career training necessary to establish a translational research program investigating mechanisms underlying skeletal...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports research on the effects of post-translational modifications of myosin and its chaperone UNC-45 that occur with adult aging. The $576,893 award, spanning September 2024 to May 2029, will test the hypothesis that age-associated chemical modifications of these proteins reduce their stability and function, ultimately contributing to sarcopenia (age-related muscle loss and...
This Project Grant award of $458,907 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to investigate the role of the gut microbiome in treating skeletal muscle atrophy. The research aims to determine if cecal microbial transplant from exercise-trained mice can attenuate muscle atrophy in male mice and fast-twitch muscles, and explore the potential of a...
The National Institute on Aging (NIA) awarded a $673,650 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Mayo Clinic in Rochester, Minnesota. The purpose of this 5-year award, with a period of performance from July 2024 to June 2029, is to evaluate the hypothesis that inflamed adipose tissue secretes factors that activate inflammatory pathways in skeletal muscle, potentially interfering with the muscle's response to exercise in older adults. The research aims to...
This $381,507 Project Grant award from the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research) supports research conducted by the University of Iowa aimed at understanding the role of the protein kinase ULK2 in the selective degradation of protein aggregates and its impact on preserving skeletal muscle quality across the lifespan. The study will use adult and aging mouse models to investigate how ULK2 and its binding partner FIP200 regulate the autophagic...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $193,188 to the University of Florida to conduct research on targeting mitochondrial permeability transition as a means to attenuate adverse muscle impact in sepsis. The research aims to explore how mitochondrial permeability transition in skeletal muscle can contribute to muscle...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $180,007 in funding to the University of North Florida to characterize the functional role of the protein DUSP4 in regulating skeletal muscle mass and strength. The researchers will use in vivo electroporation techniques in mice to either knockdown or overexpress DUSP4 and then measure changes in muscle weight, myofiber size,...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $437,154 project grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Texas Health Science Center at Houston. This 5-year grant, effective July 1, 2024, will support research to investigate the role of skeletal muscle alpha-actin in skeletal myocyte differentiation and its disruption in intranuclear rod myopathy, a severe congenital myopathy. The project aims to...
This federal Project Grant award for $473,377, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA Program 93.846 Arthritis, Musculoskeletal and Skin Diseases Research, supports research to improve skeletal muscle regeneration using human pluripotent stem cells (hPSCs). The key objectives are to: 1) Interrogate how muscle cells arise and develop from hPSCs, 2) Understand how to support hPSC-derived muscle cells by building an in vitro niche, and...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund research into the mechanisms behind stretch activation (SA) and its role in skeletal muscle endurance. The primary objectives are to: 1) Test the hypothesis that SA is an alternative way to maintain force production that contributes to mammalian skeletal muscle endurance, 2) Determine...